Basal cell carcinomas: attack of the hedgehog (original) (raw)

• Miller, D. L. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30, 774–778 (1994).
  Article CAS PubMed Google Scholar
• Housman, T. S. et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48, 425–429 (2003).
  Article PubMed Google Scholar
• Rubin, A. I., Chen, E. H. & Ratner, D. Basal-cell carcinoma. N. Eng. J. Med. 353, 2262–2269 (2005). This paper gives an authoritative, more complete review of the more clinical aspects of this tumour.
  Article CAS Google Scholar
• Karagas, M. R. et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J. Natl Cancer Inst. 94, 224–226 (2002).
  Article PubMed Google Scholar
• Marcil, I. & Stern, R. S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch. Dermatol. 136, 1524–1530 (2000).
  Article CAS PubMed Google Scholar
• Karagas, M. R. et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 267, 3305–3310 (1992).
  Article CAS PubMed Google Scholar
• Chuang, T. Y., Reizner, G. T., Elpern, D. J., Stone, J. L. & Farmer, E. R. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J. Am. Acad. Dermatol. 33, 422–426 (1995).
  Article CAS PubMed Google Scholar
• Chuang, T. Y., Reizner, G. T., Elpern, D. J., Stone, J. L. & Farmer, E. R. Non-melanoma skin cancer and keratoacanthoma in Filipinos: an incidence report from Kauai, Hawaii. Int. J. Dermatol. 32, 717–718 (1993).
  Article CAS PubMed Google Scholar
• Hoshida, Y. et al. Cancer risk after renal transplantation in Japan. Int. J. Cancer 71, 517–520 (1997).
  Article CAS PubMed Google Scholar
• Kricker, A., Armstrong, B. K., English, D. R. & Heenan, P. J. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int. J. Cancer 60, 489–494 (1995).
  Article CAS PubMed Google Scholar
• Rosso, S. et al. The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br. J. Cancer 73, 1447–1454 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Thompson, S. C., Jolley, D. & Marks, R. Reduction of solar keratoses by regular sunscreen use. N. Engl. J. Med. 329, 1147–1151 (1993).
  Article CAS PubMed Google Scholar
• Pandeya, N., Purdie, D. M., Green, A. & Williams, G. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial. Am. J. Epidemiol. 161, 748–754 (2005).
  Article PubMed Google Scholar
• van der Pols, J. C., Williams, G. M., Pandeya, N., Logan, V. & Green, A. C. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol. Biomarkers Prev. 15, 2546–2548 (2006).
  Article PubMed Google Scholar
• Kricker, A., Armstrong, B. K., English, D. R. & Heenan, P. J. A dose-response curve for sun exposure and basal cell carcinoma. Int. J. Cancer 60, 482–488 (1995).
  Article CAS PubMed Google Scholar
• Guo, H. R., Yu, H. S., Hu, H. & Monson, R. R. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control 12, 909–916 (2001).
  Article CAS PubMed Google Scholar
• Karagas, M. R. et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 153, 559–565 (2001).
  Article CAS PubMed Google Scholar
• Karagas, M. R., Stukel, T. A. & Tosteson, T. D. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int. J. Hyg. Environ. Health 205, 85–94 (2002).
  Article CAS PubMed Google Scholar
• Gailani, M. R. et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 69, 111–117 (1992).
  Article CAS PubMed Google Scholar
• Hahn, H. et al. Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851 (1996).
  Article CAS PubMed Google Scholar
• Johnson, R. L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668–1671 (1996). References 19–21 provide the original data linking basal cell carcinogenesis to aberrant activation of HH signalling.
  Article CAS PubMed Google Scholar
• Klein, R. D., Dykas, D. J. & Bale, A. E. Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory. Genet. Med. 7, 611–619 (2005).
  Article CAS PubMed Google Scholar
• Ling, G. et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 20, 7770–7778 (2001).
  Article CAS PubMed Google Scholar
• Ouhtit, A. et al. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J. Natl Cancer Inst. 90, 523–531 (1998).
  Article CAS PubMed Google Scholar
• Hutchin, M. E. et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 19, 214–223 (2005). This paper illustrates the requirement for continued HH signalling for BCC maintenance in a murine model of HH-driven BCC carcinogenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Adolphe, C., Hetherington, R., Ellis, T. & Wainwright, B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 66, 2081–2088 (2006).
  Article CAS PubMed Google Scholar
• Gailani, M. R. et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet. 14, 78–81 (1996).
  Article CAS PubMed Google Scholar
• Aszterbaum, M. et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J. Invest. Dermatol. 110, 885–888 (1998).
  Article CAS PubMed Google Scholar
• Xie, J. et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90–92 (1998).
  Article CAS PubMed Google Scholar
• Reifenberger, J. et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 58, 1798–1803 (1998).
  CAS PubMed Google Scholar
• Lum, L. & Beachy, P. A. The Hedgehog response network: sensors, switches, and routers. Science 304, 1755–1759 (2004).
  Article CAS PubMed Google Scholar
• Rohatgi, R. & Scott, M. P. Patching the gaps in Hedgehog signalling. Nature Cell Biol. 9, 1005–1009 (2007).
  Article CAS PubMed Google Scholar
• Varjosalo, M. & Taipale, J. Hedgehog signaling. J. Cell Sci. 120, 3–6 (2007).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. et al. Identification of an amplified, highly expressed gene in a human glioma. Science 236, 70–73 (1987).
  Article CAS PubMed Google Scholar
• Bhatia, N. et al. Gli2 is targeted for ubiquitination and degradation by β-TrCP ubiquitin ligase. J. Biol. Chem. 281, 19320–19326 (2006).
  Article CAS PubMed Google Scholar
• Huntzicker, E. G. et al. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev. 20, 276–281 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, J. Regulation of Hh/Gli signaling by dual ubiquitin pathways. Cell Cycle 5, 2457–2463 (2006).
  Article CAS PubMed Google Scholar
• Pan, Y., Bai, C. B., Joyner, A. L. & Wang, B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol. Cell. Biol. 26, 3365–3377 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Huangfu, D. et al. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 426, 83–87 (2003).
  Article CAS PubMed Google Scholar
• Huangfu, D. & Anderson, K. V. Cilia and Hedgehog responsiveness in the mouse. Proc. Natl Acad. Sci. USA 102, 11325–11330 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Corbit, K. C. et al. Vertebrate Smoothened functions at the primary cilium. Nature 437, 1018–1021 (2005).
  Article CAS PubMed Google Scholar
• May, S. R. et al. Loss of the retrograde motor for IFT disrupts localization of Smo to cilia and prevents the expression of both activator and repressor functions of Gli. Dev. Biol. 287, 378–389 (2005).
  Article CAS PubMed Google Scholar
• Rohatgi, R., Milenkovic, L. & Scott, M. P. Patched1 regulates hedgehog signaling at the primary cilium. Science 317, 372–376 (2007).
  Article CAS PubMed Google Scholar
• Bonifas, J. M. et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J. Invest. Dermatol. 116, 739–742 (2001).
  Article CAS PubMed Google Scholar
• Tojo, M., Kiyosawa, H., Iwatsuki, K. & Kaneko, F. Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma. Br. J. Dermatol. 146, 69–73 (2002).
  Article CAS PubMed Google Scholar
• Ashton, K. J., Weinstein, S. R., Maguire, D. J. & Griffiths, L. R. Molecular cytogenetic analysis of basal cell carcinoma DNA using comparative genomic hybridization. J. Invest. Dermatol. 117, 683–686 (2001).
  Article CAS PubMed Google Scholar
• Reifenberger, J. et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br. J. Dermatol. 152, 43–51 (2005).
  Article CAS PubMed Google Scholar
• Lindstrom, E., Shimokawa, T., Toftgard, R. & Zaphiropoulos, P. G. PTCH mutations: distribution and analyses. Hum. Mutat. 27, 215–219 (2006).
  Article CAS PubMed Google Scholar
• Bodak, N. et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc. Natl Acad. Sci. USA 96, 5117–5122 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Daya-Grosjean, L. & Sarasin, A. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat. Res. 450, 193–199 (2000).
  Article CAS PubMed Google Scholar
• Couve-Privat, S., Bouadjar, B., Avril, M. F., Sarasin, A. & Daya-Grosjean, L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 62, 7186–7189 (2002).
  CAS PubMed Google Scholar
• Moriwaki, S., Ray, S., Tarone, R. E., Kraemer, K. H. & Grossman, L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat. Res. 364, 117–123 (1996).
  Article PubMed Google Scholar
• Rees, J. L. The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75, 739–751 (2004). This remains an authoritative review of genetic factors predisposing to UV-induced skin cancers.
  Article CAS PubMed PubMed Central Google Scholar
• Han, J., Kraft, P., Colditz, G. A., Wong, J. & Hunter, D. J. Melanocortin 1 receptor variants and skin cancer risk. Int. J. Cancer 119, 1976–1984 (2006).
  Article CAS PubMed Google Scholar
• Liboutet, M. et al. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J. Invest. Dermatol. 126, 1510–1517 (2006).
  Article CAS PubMed Google Scholar
• Box, N. F. et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J. Invest. Dermatol. 116, 224–229 (2001).
  Article CAS PubMed Google Scholar
• Bastiaens, M. T. et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884–894 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gerstenblith, M. R., Goldstein, A. M., Fargnoli, M. C., Peris, K. & Landi, M. T. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum. Mutat. 28, 495–505 (2007).
  Article CAS PubMed Google Scholar
• Palmer, J. S. et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176–186 (2000).
  Article CAS PubMed Google Scholar
• Kennedy, C. et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294–300 (2001).
  Article CAS PubMed Google Scholar
• Slominski, A., Paus, R. & Wortsman, J. Can some melanotropins modulate keratinocyte proliferation? J. Invest. Dermatol. 97, 747 (1991).
  Article CAS PubMed Google Scholar
• Wintzen, M., Yaar, M., Burbach, J. P. & Gilchrest, B. A. Proopiomelanocortin gene product regulation in keratinocytes. J. Invest. Dermatol. 106, 673–678 (1996).
  Article CAS PubMed Google Scholar
• Corre, S. et al. UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J. Biol. Chem. 279, 51226–51233 (2004).
  Article CAS PubMed Google Scholar
• Cui, R. et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853–864 (2007).
  Article CAS PubMed Google Scholar
• Gudbjartsson, D. F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nature Genet. 40, 886–891 (2008). This is a recent large-scale survey of genetic variants predisposing to BCC carcinogenesis.
  Article CAS PubMed Google Scholar
• Kraemer, K. H., Lee, M. M., Andrews, A. D. & Lambert, W. C. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. Arch. Dermatol. 130, 1018–1021 (1994).
  Article CAS PubMed Google Scholar
• Berwick, M. & Vineis, P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl Cancer Inst. 92, 874–897 (2000).
  Article CAS PubMed Google Scholar
• Wei, Q., Matanoski, G. M., Farmer, E. R., Hedayati, M. A. & Grossman, L. DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J. Invest. Dermatol. 104, 933–936 (1995).
  Article CAS PubMed Google Scholar
• Dybdahl, M., Frentz, G., Vogel, U., Wallin, H. & Nexo, B. A. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutat. Res. 433, 15–22 (1999).
  Article CAS PubMed Google Scholar
• Segerback, D., Strozyk, M., Snellman, E., & Hemminki, K. Repair of UV dimers in skin DNA of patients with basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 17, 2388–2392 (2008).
  Article PubMed Google Scholar
• Han, S. et al. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur. J. Hum. Genet. 14, 1136–1144 (2006).
  Article CAS PubMed Google Scholar
• Han, J., Colditz, G. A., Samson, L. D. & Hunter, D. J. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res. 64, 3009–3013 (2004).
  Article CAS PubMed Google Scholar
• Thirumaran, R. K. et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27, 1676–1681 (2006).
  Article CAS PubMed Google Scholar
• Jacobsen, N. R. et al. No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol. Biomarkers Prev. 12, 584–585 (2003).
  CAS PubMed Google Scholar
• Festa, F. et al. Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat. Res. 574, 105–111 (2005).
  Article CAS PubMed Google Scholar
• Chen, Y. C. et al. Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan. J. Environ. Sci. Health A Tox Hazard Subst. Environ. Eng. 38, 201–211 (2003).
  Article PubMed CAS Google Scholar
• Han, J., Cox, D. G., Colditz, G. A. & Hunter, D. J. The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women. Mol. Carcinog. 45, 694–700 (2006).
  Article CAS PubMed Google Scholar
• Stefanaki, I. et al. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. Br. J. Dermatol. 156, 357–362 (2007).
  Article CAS PubMed Google Scholar
• McGregor, J. M. et al. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol. 119, 84–90 (2002).
  Article CAS PubMed Google Scholar
• Wilkening, S. et al. No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin. Br. J. Dermatol. 157, 375–377 (2007).
  Article CAS PubMed Google Scholar
• Asplund, A. et al. PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer. Br. J. Dermatol. 152, 868–873 (2005).
  Article CAS PubMed Google Scholar
• Wakabayashi, Y., Mao, J. H., Brown, K., Girardi, M. & Balmain, A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445, 761–765 (2007).
  Article CAS PubMed Google Scholar
• Yoon, J. W. et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem. 277, 5548–5555 (2002).
  Article CAS PubMed Google Scholar
• Howell, B. G. et al. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior. J. Dermatol. Sci. 39, 39–51 (2005).
  Article CAS PubMed Google Scholar
• O'Driscoll, L. et al. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol. Cancer 5, 74 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Yu, M. et al. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J. Invest. Dermatol. 128, 1797–1805 (2008).
  Article CAS PubMed Google Scholar
• Asplund, A. et al. Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma. Br. J. Dermatol. 158, 527–538 (2008).
  Article CAS PubMed Google Scholar
• Xie, J. et al. A role of PDGFRα in basal cell carcinoma proliferation. Proc. Natl Acad. Sci. USA 98, 9255–9259 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Bigelow, R. L. et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J. Biol. Chem. 279, 1197–1205 (2004).
  Article CAS PubMed Google Scholar
• Regl, G. et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64, 7724–7731 (2004).
  Article CAS PubMed Google Scholar
• Kump, E., Ji, J., Wernli, M., Hausermann, P. & Erb, P. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene 27, 3856–3864 (2008).
  Article CAS PubMed Google Scholar
• Li, C. et al. IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras–Erk signaling. Oncogene 23, 1608–1617 (2004).
  Article CAS PubMed Google Scholar
• Athar, M. et al. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res. 64, 7545–7552 (2004).
  Article CAS PubMed Google Scholar
• Leung, C. et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337–341 (2004).
  Article CAS PubMed Google Scholar
• Reinisch, C. M., Uthman, A., Erovic, B. M. & Pammer, J. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J. Cutan. Pathol. 34, 174–180 (2007).
  Article PubMed Google Scholar
• Kenney, A. M. & Rowitch, D. H. Sonic hedgehog promotes G1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol. Cell. Biol. 20, 9055–9067 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Rao, G. et al. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 23, 6156–6162 (2004).
  Article CAS PubMed Google Scholar
• Hahn, H. et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J. Biol. Chem. 15, 28341–28344 (2000).
  Article Google Scholar
• Levitt, R. J., Zhao, Y., Blouin, M. J. & Pollak, M. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells. Cancer Lett. 255, 300–306 (2007).
  Article CAS PubMed Google Scholar
• Lipinski, R. J. et al. Sonic hedgehog signaling regulates the expression of insulin-like growth factor binding protein-6 during fetal prostate development. Dev. Dyn. 233, 829–836 (2005).
  Article CAS PubMed Google Scholar
• Allan, G. J. et al. Major components of the insulin-like growth factor axis are expressed early in chicken embryogenesis, with IGF binding protein (IGFBP)-5 expression subject to regulation by sonic hedgehog. Anat. Embryol. (Berl.) 207, 73–84 (2003).
  Article CAS Google Scholar
• Elia, D., Madhala, D., Ardon, E., Reshef, R. & Halevy, O. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim. Biophys. Acta 1773, 1438–1446 (2007).
  Article CAS PubMed Google Scholar
• Riobo, N. A., Lu, K., Ai, X., Haines, G. M. & Emerson, C. P., Jr. Phosphoinositide 3-kinase and Akt are essential for sonic hedgehog signaling. Proc. Natl Acad. Sci. USA 103, 4505–4510 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Teh, M. T. et al. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 62, 4773–4780 (2002).
  CAS PubMed Google Scholar
• Yoshida, Y., Wang, I. C., Yoder, H. M., Davidson, N. O. & Costa, R. H. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology 132, 1420–1431 (2007).
  Article CAS PubMed Google Scholar
• Dai, B. et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26, 6212–6219 (2007).
  Article CAS PubMed Google Scholar
• Liu, M. et al. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 66, 3593–3602 (2006).
  Article CAS PubMed Google Scholar
• Kalin, T. V. et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res. 66, 1712–1720 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, I. M. et al. The forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 66, 2153–2161 (2006).
  Article CAS PubMed Google Scholar
• Tan, Y., Raychaudhuri, P. & Costa, R. H. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol. Cell. Biol. 27, 1007–1016 (2007).
  Article CAS PubMed Google Scholar
• Schuller, U. et al. Forkhead transcription factor FoxM1 regulates mitotic entry and prevents spindle defects in cerebellar granule neuron precursors. Mol. Cell. Biol. 27, 8259–8270 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wonsey, D. R. & Follettie, M. T. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65, 5181–5189 (2005).
  Article CAS PubMed Google Scholar
• Kalinichenko, V. V. et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 18, 830–850 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gusarova, G. A. et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J. Clin. Invest. 117, 99–111 (2007).
  Article CAS PubMed Google Scholar
• Radhakrishnan, S. K. et al. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 66, 9731–9735 (2006).
  Article CAS PubMed Google Scholar
• Eichberger, T. et al. FOXE1, a new transcriptional target of GLI2, is expressed in human epidermis and basal cell carcinoma. J. Invest. Dermatol. 122, 1180–1187 (2004).
  Article CAS PubMed Google Scholar
• Brancaccio, A. et al. Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. Hum. Mol. Genet. 13, 2595–2606 (2004).
  Article CAS PubMed Google Scholar
• Yang, S. H. et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling. Nature Genet. 40, 1130–1135 (2008).
  Article CAS PubMed Google Scholar
• Nilsson, M. et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl Acad. Sci. USA 97, 3438–3443 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Grachtchouk, M. et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nature Genet. 24, 216–217 (2000).
  Article CAS PubMed Google Scholar
• Aszterbaum, M. et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nature Med. 5, 1285–1291 (1999).
  Article CAS PubMed Google Scholar
• Svard, J. et al. Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev. Cell 10, 187–197 (2006).
  Article PubMed CAS Google Scholar
• Grachtchouk, V. et al. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J. 22, 2741–2751 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Wetmore, C., Eberhart, D. E. & Curran, T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 61, 513–516 (2001).
  CAS PubMed Google Scholar
• Hadley, M. E. & Dorr, R. T. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27, 921–930 (2006).
  Article CAS PubMed Google Scholar
• Gange, R. W., Blackett, A. D., Matzinger, E. A., Sutherland, B. M. & Kochevar, I. E. Comparative protection efficiency of UVA- and UVB-induced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J. Invest. Dermatol. 85, 362–364 (1985).
  Article CAS PubMed Google Scholar
• Eller, M. S., Asarch, A. & Gilchrest, B. A. Photoprotection in human skin — a multifaceted SOS response. Photochem. Photobiol. 84, 339–349 (2008).
  Article CAS PubMed Google Scholar
• Arad, S. et al. Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1 +/− mice. Am. J. Pathol. 172, 1248–1255 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Yarosh, D. B. & Klein, J. DNA repair enzymes in prevention of photocarcinogenesis. Photochem. Photobiol. 63, 445–447 (1996).
  Article CAS PubMed Google Scholar
• Yarosh, D. et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 357, 926–929 (2001).
  Article CAS PubMed Google Scholar
• Peck, G. L. et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J. Am. Acad. Dermatol. 19, 176–185 (1988).
  Article CAS PubMed Google Scholar
• Goldberg, L. H., Hsu, S. H. & Alcalay, J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J. Am. Acad. Dermatol. 21, 144–145 (1989).
  Article CAS PubMed Google Scholar
• Kraemer, K. H., DiGiovanna, J. J., Moshell, A. N., Tarone, R. E. & Peck, G. L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med. 318, 1633–1637 (1988).
  Article CAS PubMed Google Scholar
• Tangrea, J. A. et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J. Natl Cancer Inst. 84, 328–332 (1992).
  Article CAS PubMed Google Scholar
• Levine, N. et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized double-blind, controlled trial. Cancer Epidemiol. Biomarkers Prevention 6, 957–961 (1997).
  CAS Google Scholar
• Peris, K., Fargnoli, M. C. & Chimenti, S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N. Engl. J. Med. 341, 1767–1768 (1999).
  Article CAS PubMed Google Scholar
• Duvic, M. et al. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J. Invest. Dermatol. 121, 902–909 (2003).
  Article CAS PubMed Google Scholar
• Bianchi, L. et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br. J. Dermatol. 151, 148–156 (2004).
  Article CAS PubMed Google Scholar
• So, P. L. et al. Topical tazarotene chemoprevention reduces basal cell carcinoma number and size in Ptch1 +/− mice exposed to ultraviolet or ionizing radiation. Cancer Res. 64, 4385–4389 (2004).
  Article CAS PubMed Google Scholar
• So, P. L., Fujimoto, M. A. & Epstein, E. H. Jr. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis. Mol. Cancer Ther. 7, 1275–1284 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Black, H. S. et al. Evidence that a low-fat diet reduces the occurence of non-melanoma skin cancer. Int. J. Cancer 62, 165–169 (1995).
  Article CAS PubMed Google Scholar
• Carneiro, B. A., Watkin, W. G., Mehta, U. K. & Brockstein, B. E. Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest. 24, 396–400 (2006).
  Article PubMed Google Scholar
• Binns, W., James, L. F., Shupe, J. L. & Everett, G. A congenital cyclopian-type malformation in lambs induced by maternal ingestion of a range plant, Veratrum californicum. Am. J. Vet. Res. 24, 1164–1175 (1963).
  CAS PubMed Google Scholar
• Tabs, S. & Avci, O. Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity. Eur. J. Dermatol. 14, 96–102 (2004).
  PubMed Google Scholar
• Cooper, M. K., Porter, J. A., Young, K. E. & Beachy, P. A. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280, 1603–1607 (1998).
  Article CAS PubMed Google Scholar
• Incardona, J. P., Gaffield, W., Kapur, R. P. & Roelink, H. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125, 3553–3562 (1998).
  CAS PubMed Google Scholar
• Chen, J. K., Taipale, J., Cooper, M. K. & Beachy, P. A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743–2748 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005–1009 (2000).
  Article CAS PubMed Google Scholar
• Van Hoff, D. D. et al. Efficacy data of GDC-0449, a systemic Hedgehog (Hh) pathway antagonist, in a first-in-human, first-in-class, phase I study with locally advanced, multifocal or metastatic basal cell carcinoma patients. Proc. 99th Annu. Meeting Am. Assoc. Cancer Res. abstract LB-138 (2008).
• Palma, V. et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 132, 335–344 (2005).
  Article CAS PubMed Google Scholar
• Balordi, F. & Fishell, G. Mosaic removal of hedgehog signaling in the adult SVZ reveals that the residual wild-type stem cells have a limited capacity for self-renewal. J. Neurosci. 27, 14248–14259 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, C. L., Zou, Y., He, W., Gage, F. H. & Evans, R. M. A role for adult TLX-positive neural stem cells in learning and behaviour. Nature 451, 1004–1007 (2008).
  Article CAS PubMed Google Scholar
• Paladini, R. D., Saleh, J., Qian, C., Xu, G. X. & Rubin, L. L. Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway. J. Invest. Dermatol. 125, 638–646 (2005).
  Article CAS PubMed Google Scholar
• Miura, H., Kusakabe, Y. & Harada, S. Cell lineage and differentiation in taste buds. Arch. Histol. Cytol. 69, 209–225 (2006).
  Article CAS PubMed Google Scholar
• Angot, E. et al. Chemoattractive activity of sonic hedgehog in the adult subventricular zone modulates the number of neural precursors reaching the olfactory bulb. Stem Cells 10 Jul 2008 [epub ahead of print].
• Kimura, H., Ng, J. M. & Curran, T. Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13, 249–260 (2008).
  Article CAS PubMed Google Scholar
• Arad, S., Konnikov, N., Goukassian, D. A. & Gilchrest, B. A. Quantification of inducible SOS-like photoprotective responses in human skin. J. Invest. Dermatol. 127, 2629–2636 (2007).
  Article CAS PubMed Google Scholar
• Bijlsma, M. F. et al. Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol. 4, e232 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Holick, M. F. et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210, 203–205 (1980).
  Article CAS PubMed Google Scholar
• MacLaughlin, J. & Holick, M. F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 76, 1536–1538 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Vogt, A., Hebert, J., Hwang, J., Lu, Y. & Epstein, E. H. Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1 +/− mice. J. Invest. Dermatol. 124, 263–267 (2005).
  Article CAS PubMed Google Scholar
• Karhadkar, S. S. et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707–712 (2004).
  Article CAS PubMed Google Scholar
• Van Scott, E. J. & Reinertson, R. P. The modulating influence of stromal environment on epithelial cells studies in human autoransplants. J. Invest. Dermatol. 36, 109–131 (1961).
  Article CAS PubMed Google Scholar
• Williams, T. et al. The oncogenic GLI (GLI1 and GLI2) transcription factors induce characteristics of cellular senescence in N/Tert-1 keratinocytes. J. Invest. Dermatol. 127, s92 (2007).
  Article CAS Google Scholar
• Gorlin, R. J. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66, 98–113 (1987).
  Article CAS Google Scholar
• Evans, D. G. R., Farndon, P. A., Burnell, L. D., Gattamaneni, H. R. & Birch, J. M. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br. J. Cancer 64, 959–961 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, A. D., Hebert, A. A. & Esterly, N. B. Nevoid basal cell carcinoma syndrome: bilateral ovarian fibromas in a 3 1/2-year-old girl. J. Am. Acad. Dermatol. 14, 371–374 (1986). References 165–167 review the clinical aspects of BCNS.
  Article CAS PubMed Google Scholar
• Kimonis, V. E. et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am. J. Med. Genet. 69, 299–308 (1997).
  Article CAS PubMed Google Scholar
• Miller, K. L. et al. XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 27, 1670–1675 (2006).
  Article CAS PubMed Google Scholar
• Kang, S. Y. et al. Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population. Cancer Sci. 98, 716–720 (2007).
  Article CAS PubMed Google Scholar
• Han, J., Hankinson, S. E., Colditz, G. A. & Hunter, D. J. Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br. J. Cancer 91, 1604–1609 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Dybdahl, M., Vogel, U., Frentz, G., Wallin, H. & Nexo, B. A. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 8, 77–81 (1999).
  CAS PubMed Google Scholar
• Lovatt, T. et al. Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6–exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum. Mutat. 25, 353–359 (2005).
  Article CAS PubMed Google Scholar
• Vogel, U. et al. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect. Prev. 29, 209–214 (2005).
  Article CAS PubMed Google Scholar
• Han, J., Colditz, G. A. & Hunter, D. J. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk. Cancer Epidemiol. Biomarkers Prev. 15, 592–593 (2006).
  Article PubMed Google Scholar
• Lin, Q. et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Res. 66, 87–94 (2006).
  Article CAS PubMed Google Scholar
• Meeran, S. M., Mantena, S. K., Meleth, S., Elmets, C. A. & Katiyar, S. K. Interleukin-12-deficient mice are at greater risk of UV radiation-induced skin tumors and malignant transformation of papillomas to carcinomas. Mol. Cancer Ther. 5, 825–832 (2006).
  Article CAS PubMed Google Scholar
• Schwarz, T. Photoimmunosuppression. Photodermatol. Photoimmunol. Photomed. 18, 141–145 (2002).
  Article CAS PubMed Google Scholar
• Reynolds, N. J., Todd, C. & Angus, B. Overexpression of protein kinase C-α and -β isozymes by stromal dendritic cells in basal and squamous cell carcinoma. Br. J. Dermatol. 136, 666–673 (1997).
  Article CAS PubMed Google Scholar
• Neill, G. W. et al. Loss of protein kinase Cα expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res. 63, 4692–4697 (2003).
  CAS PubMed Google Scholar
• Riobo, N. A., Haines, G. M. & Emerson, C. P. Jr. Protein kinase C-δ and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res. 66, 839–845 (2006).
  Article CAS PubMed Google Scholar
• Lauth, M., Bergstrom, A. & Toftgard, R. Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli. Oncogene 26, 5163–5168 (2007).
  Article CAS PubMed Google Scholar
• Tang, X. et al. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1 +/− mice. J. Clin. Invest. 113, 867–875 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Thyberg, J. & Fredholm, B. B. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp. Cell Res. 170, 160–169 (1987).
  Article CAS PubMed Google Scholar
• Kasper, M. et al. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol. Cell. Biol. 26, 6283–6298 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Mimeault, M. et al. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol. Cancer Ther. 6, 967–978 (2007).
  Article CAS PubMed Google Scholar
• Ikeuchi, T., Urano, Y., Fukuhara, K., Nakanishi, H. & Arase, S. Light microscopic autoradiographical analysis of [125I]epidermal growth factor binding in basal cell epithelioma and squamous cell carcinoma of the skin. J. Dermatol. 20, 219–225 (1993).
  Article CAS PubMed Google Scholar
• Mimeault, M. et al. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. Int. J. Cancer 118, 1022–1031 (2006).
  Article CAS PubMed Google Scholar
• Hu, W. G., Liu, T., Xiong, J. X. & Wang, C. Y. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells. Acta Pharmacol. Sin. 28, 1224–1230 (2007).
  Article CAS PubMed Google Scholar
• Neill, G. W. et al. GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes. Carcinogenesis 29, 738–746 (2008).
  Article CAS PubMed Google Scholar
• Dennler, S. et al. Induction of sonic hedgehog mediators by transforming growth factor-β: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67, 6981–6986 (2007).
  Article CAS PubMed Google Scholar
• Stamp, G. W. et al. Transforming growth factor-β distribution in basal cell carcinomas: relationship to proliferation index. Br. J. Dermatol. 129, 57–64 (1993).
  Article CAS PubMed Google Scholar
• Gambichler, T. et al. Increased expression of TGF-β/Smad proteins in basal cell carcinoma. Eur. J. Med. Res. 12, 509–514 (2007).
  CAS PubMed Google Scholar
• Verhaegh, M. E., Arends, J. W., Majoie, I. M., Hoekzema, R. & Neumann, H. A. Transforming growth factor-β and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol. Surg. 23, 695–700 (1997).
  CAS PubMed Google Scholar
• Lange, D. et al. Expression of TGF-β related Smad proteins in human epithelial skin tumors. Int. J. Oncol. 14, 1049–1056 (1999).
  CAS PubMed Google Scholar
• Sneddon, J. B. et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl Acad. Sci. USA 103, 14842–14847 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Thelu, J., Rossio, P. & Favier, B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol. 2, 7 (2002).
  Article PubMed PubMed Central Google Scholar
• Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nature Genet. 33, 416–421 (2003).
  Article CAS PubMed Google Scholar
• Christenson, L. J. et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294, 681–690 (2005).
  Article CAS PubMed Google Scholar